
ORAL, BUT NOT INTRAVENOUS, ALLOANTIGEN PREVENTS ACCELERATED ALLOGRAFT REJECTION BY SELECTIVE INTRAGRAFT TH2 CELL ACTIVATION
HANCOCK, WAYNE W., SAYEGH, MOHAMED H., KWOK, CHENG A., WEINER, HOWARD L., CARPENTER, CHARLES B.Volume:
55
Journal:
Transplantation
DOI:
10.1097/00007890-199305000-00034
Date:
May, 1993
Fichier:
PDF, 762 KB
1993